This meeting took place in 2014


Here are the related meetings in 2017:
Cell Plasticity within the Tumor Microenvironment (A1)
Inflammation-Driven Cancer: Mechanisms to Therapy (J7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Inflammation, Infection and Cancer (X1)


Organizer(s) Johanna A. Joyce, Timothy C. Wang and Frances R. Balkwill
March 9—14, 2014
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Discounted Abstract Deadline: Nov 6, 2013
Abstract Deadline: Dec 10, 2013
Scholarship Deadline: Nov 6, 2013
Discounted Registration Deadline: Jan 9, 2014

Sponsored by BioLegend, Inc., Infinity Pharmaceuticals, Inc. and Roche


Summary of Meeting:
For many years, the presence of leukocytes in tumors had been thought to be a consequence of a failed attempt at cancer cell destruction. However, in the past decade it has emerged that tumors are not only effective in escaping from immune-mediated rejection, they also modify certain inflammatory cell types to render them tumor promoting rather than tumor suppressive. Indeed, inflammatory cells are an important component of the tumor microenvironment, and numerous clinical studies have established a positive correlation between inflammation and cancer progression. This conference will cover the latest research on the roles of inflammation and inflammatory cell subtypes on cancer initiation and progression. A special focus will be placed on emerging findings regarding the contributions of the host microbiome and infectious agents in eliciting an initial inflammatory response, and how that predisposes to specific types of cancer. Throughout the meeting there will be an emphasis placed not only on the mechanisms underlying the critical functions of infection and inflammation in cancers, but also on how to therapeutically target these processes in cancer. A critical component of this conference on “Inflammation, Infection and Cancer” will be the joint sessions held with the companion meeting on “Immune Evolution in Cancer”, emphasizing the latest results in understanding and therapeutically targeting the functions of different immune cells in the tumor microenvironment.

View Meeting Program

Scholarships/Awards

Keystone Symposia Future of Science Fund Scholarship Recipients

Santiago Pablo Zelenay
Cancer Research UK, London Research Institute, UK

National Institute of General Medical Sciences (NIGMS) Ancillary Training Program Scholarship Recipients

Curtis J. Henry
Emory University School of Medicine, USA

Lee Rivera
University of California, San Francisco, USA

National Cancer Institute (NCI) Scholarship Recipients

Liane Babes
University of Calgary, Canada

Serena Zilio
University of Miami, USA

The Elkes Foundation Scholarship Recipients

Ruth A. Franklin
Yale School of Medicine, USA